FUSITAB Trademark
Trademark Overview
On Monday, October 16, 2000, a trademark application was filed for FUSITAB with the United States Patent and Trademark Office. The USPTO has given the FUSITAB trademark a serial number of 78030862. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Sunday, March 7, 2010. This trademark is owned by Oxford BioMedica plc. The FUSITAB trademark is filed in the Pharmaceutical Products, Medical Instrument Products, and Computer & Software Services & Scientific Services categories with the following description:
Gene therapy and prophylaxis products, namely, clinical, medical reagents for use in gene therapy; pharmaceutical preparations for use in gene therapy; therapeutic compositions containing liposome reagents/nucleic acid/antibodies for gene therapy; vaccines; enzymes and enzyme preparations for medical purposes, namely, gene therapy for use in the treatment of viral and bacterial infections, cancer and bodily conditions associated with immunosystems
instruments, apparatus surgical and medical apparatus and instruments, all for the administration of gene therapy treatment and for the administration of prophylaxis products, namely, syringes, scalpels, catheters, and tubes for the administration of gene therapy products
Scientific and medical research and product development; medical services; genetic engineering services; biotechnology services, namely, research and development of new products in the field of biotechnology; scientific and medical research and development of new products in the field of gene therapy
General Information
Serial Number | 78030862 |
Word Mark | FUSITAB |
Filing Date | Monday, October 16, 2000 |
Status | 710 - CANCELLED - SECTION 8 |
Status Date | Sunday, March 7, 2010 |
Registration Number | 2747063 |
Registration Date | Tuesday, August 5, 2003 |
Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
Published for Opposition Date | Tuesday, July 2, 2002 |
Trademark Statements
Goods and Services | Gene therapy and prophylaxis products, namely, clinical, medical reagents for use in gene therapy; pharmaceutical preparations for use in gene therapy; therapeutic compositions containing liposome reagents/nucleic acid/antibodies for gene therapy; vaccines; enzymes and enzyme preparations for medical purposes, namely, gene therapy for use in the treatment of viral and bacterial infections, cancer and bodily conditions associated with immunosystems |
Goods and Services | instruments, apparatus surgical and medical apparatus and instruments, all for the administration of gene therapy treatment and for the administration of prophylaxis products, namely, syringes, scalpels, catheters, and tubes for the administration of gene therapy products |
Goods and Services | Scientific and medical research and product development; medical services; genetic engineering services; biotechnology services, namely, research and development of new products in the field of biotechnology; scientific and medical research and development of new products in the field of gene therapy |
Classification Information
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 006, 018, 044, 046, 051, 052 |
Class Status Code | 2 - Sec. 8 - Entire Registration |
Class Status Date | Sunday, March 7, 2010 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
US Class Codes | 026, 039, 044 |
Class Status Code | 2 - Sec. 8 - Entire Registration |
Class Status Date | Sunday, March 7, 2010 |
Primary Code | 010 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 2 - Sec. 8 - Entire Registration |
Class Status Date | Sunday, March 7, 2010 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | Oxford BioMedica plc |
Party Type | 30 - Original Registrant |
Legal Entity Type | 11 - Company |
Address | Oxford OX4 4GA GB |
Party Name | Oxford BioMedica plc |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 11 - Company |
Address | Oxford OX4 4GA GB |
Party Name | Oxford BioMedica plc |
Party Type | 10 - Original Applicant |
Legal Entity Type | 11 - Company |
Address | Oxford OX4 4GA GB |
Trademark Events
Event Date | Event Description |
Sunday, March 7, 2010 | CANCELLED SEC. 8 (6-YR) |
Tuesday, June 10, 2008 | CASE FILE IN TICRS |
Tuesday, August 5, 2003 | REGISTERED-PRINCIPAL REGISTER |
Monday, June 9, 2003 | Sec. 1(B) CLAIM DELETED |
Monday, March 24, 2003 | NOTICE OF ALLOWANCE CANCELLED |
Monday, November 25, 2002 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Monday, November 4, 2002 | PAPER RECEIVED |
Friday, October 4, 2002 | PAPER RECEIVED |
Tuesday, September 24, 2002 | NOA MAILED - SOU REQUIRED FROM APPLICANT |
Tuesday, July 2, 2002 | PUBLISHED FOR OPPOSITION |
Wednesday, June 12, 2002 | NOTICE OF PUBLICATION |
Saturday, March 9, 2002 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Monday, February 4, 2002 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Wednesday, November 7, 2001 | LETTER OF SUSPENSION MAILED |
Wednesday, November 7, 2001 | ASSIGNED TO EXAMINER |
Monday, October 1, 2001 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Monday, October 1, 2001 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Thursday, March 29, 2001 | NON-FINAL ACTION MAILED |
Thursday, March 22, 2001 | ASSIGNED TO EXAMINER |